Richmond Pharmacology is excited to join the Gene Therapy Forum 23-25 March 2026 in Boston, USA.

This dedicated forum brings together leaders in gene therapy research, clinical development, biotechnology, regulation, and manufacturing to explore the latest advances in genetic medicine and the translation of innovative therapies into the clinic.

Representing Richmond Pharmacology:

  • Dr Jörg Taubel, Chief Executive Officer

Our Focus at the Forum

  • Advances in gene therapy platforms and delivery technologies
  • Clinical translation strategies for next‑generation genetic medicines
  • Safety, regulatory, and manufacturing considerations
  • Designing early‑phase and first‑in‑human gene therapy trials
  • Strengthening partnerships across academia, biotech, and clinical research

Connect With Us

If you are attending the Gene Therapy Forum 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: Gene Therapy Forum Conference

Latest news

Leadership Spotlight- Head of Acute Clinical Management

February 20, 2026
In this edition, we spotlight Carolina Pacheco de Amorim, who leads Acute Clinical Management (ACM)
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event